These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34692486)
21. Gene Signatures and Prognostic Values of m Lu S; Yu Z; Xiao Z; Zhang Y Front Oncol; 2020; 10():875. PubMed ID: 32596151 [TBL] [Abstract][Full Text] [Related]
22. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy. Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035 [TBL] [Abstract][Full Text] [Related]
23. Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma. He B; Zeng J; Chao W; Chen X; Huang Y; Deng K; Huang Z; Li J; Dai M; Chen S; Huang H; Dai S Oncotarget; 2017 Jun; 8(25):41166-41177. PubMed ID: 28467811 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma. Zeng X; Liu G; Pan Y; Li Y J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520 [TBL] [Abstract][Full Text] [Related]
25. Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma. Liu SL; Bian LJ; Liu ZX; Chen QY; Sun XS; Sun R; Luo DH; Li XY; Xiao BB; Yan JJ; Lu ZJ; Yan SM; Yuan L; Tang LQ; Li JM; Mai HQ J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303611 [TBL] [Abstract][Full Text] [Related]
26. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma. Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma. Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404 [TBL] [Abstract][Full Text] [Related]
28. Machine Learning Analysis of Image Data Based on Detailed MR Image Reports for Nasopharyngeal Carcinoma Prognosis. Cui C; Wang S; Zhou J; Dong A; Xie F; Li H; Liu L Biomed Res Int; 2020; 2020():8068913. PubMed ID: 32149139 [TBL] [Abstract][Full Text] [Related]
29. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma. Tian M; Yang J; Han J; He J; Liao W Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109 [TBL] [Abstract][Full Text] [Related]
31. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma. Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525 [TBL] [Abstract][Full Text] [Related]
32. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma. Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781 [TBL] [Abstract][Full Text] [Related]
33. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer. Cheng Y; Li X; Dai Y; Dong Y; Yang X; Wang J J Gynecol Oncol; 2021 May; 32(3):e30. PubMed ID: 33559412 [TBL] [Abstract][Full Text] [Related]
34. Decreased expression of nuclear factor 90 correlates with worse outcomes in nasopharyngeal carcinoma. Li Y; Fu J; Li ZZ; Zhu Q; Chen K; Du H; Liu J; Li Y Transl Cancer Res; 2021 May; 10(5):2318-2327. PubMed ID: 35116548 [TBL] [Abstract][Full Text] [Related]
35. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma. Xue Y; Li J; Lu X Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760 [TBL] [Abstract][Full Text] [Related]
36. Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma. Ouyang FS; Guo BL; Zhang B; Dong YH; Zhang L; Mo XK; Huang WH; Zhang SX; Hu QG Oncotarget; 2017 Sep; 8(43):74869-74879. PubMed ID: 29088830 [TBL] [Abstract][Full Text] [Related]
37. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma. Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525 [TBL] [Abstract][Full Text] [Related]
38. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma. Liang Y; Li J; Li Q; Tang L; Chen L; Mao Y; He Q; Yang X; Lei Y; Hong X; Zhao Y; He S; Guo Y; Wang Y; Zhang P; Liu N; Li Y; Ma J Theranostics; 2020; 10(21):9767-9778. PubMed ID: 32863958 [No Abstract] [Full Text] [Related]
39. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma. Zeng Z; Fan S; Zhang X; Li S; Zhou M; Xiong W; Tan M; Zhang W; Li G Clin Transl Oncol; 2016 Feb; 18(2):206-11. PubMed ID: 26260913 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients. Xiong Y; Shi LL; Zhu LS; Peng G Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]